Clinical trial
Single Center Safety and Tolerability Trial of Intranasal Insulin in Parkinson's Disease
NCT04251585 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Center Safety and Tolerability Trial of Intranasal Insulin in Parkinson's Disease
- Lead sponsor
- HealthPartners Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 4, 2020
- Completion date
- August 27, 2024
- Enrollment
- 31 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.